Clinical Trials List
2021-07-01 - 2026-12-31
Phase III
Recruiting6
ICD-10C15.9
Malignant neoplasm of esophagus, unspecified
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9150.9
Malignant neoplasm of esophagus, unspecified
-
Trial Applicant
Merck Sharp & Dohme (I.A.) LLC
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- Ming-Yu Lien Division of Hematology & Oncology
- Chi-Ching Chen Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Jiun-I Lai 無
- Rheun-Chuan Lee 無
- Sheng-Yu Chen 無
- Yee Chao 無
- 陳盛裕 Division of Hematology & Oncology
- Chien-An Liu Division of Radiology
- Tien-Hua Chen Division of Hematology & Oncology
- Chung-Pin Li Division of Hematology & Oncology
- Yi-Ping Hung Division of Hematology & Oncology
- 黃宣恩 Division of Radiology
- 姜乃榕 Division of Hematology & Oncology
- Chueh-Chuan Yen 醫學研究部
- Shao-Jung Hsu Division of General Internal Medicine
- Muh-Hwa Yang Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Kun-Huei Yeh Division of Hematology & Oncology
- Ann-Lii Cheng Division of Hematology & Oncology
- Chia-Chi Lin Division of Hematology & Oncology
- 郭弘揚 Division of Hematology & Oncology
- TA-CHEN HUANG Division of Hematology & Oncology
- JHE-CYUAN GUO Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Nai-Jung Chiang 未分科
- 林逢嘉 Division of Radiation Therapy
- 劉奕廷 Division of General Internal Medicine
- Wei-Lun Chang Digestive System Department
- Yau-Lin Tseng Division of Thoracic Surgery
- 姜乃榕 國衛院
- Chia-Jui Yen Division of Hematology & Oncology
- Yi-Ting Yen Division of General Surgery
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Tai-Jan Chiu Division of Hematology & Oncology
- 吳佳哲 Division of Hematology & Oncology
- 李易濰 Division of Radiology
- Yu-Li Su Division of Hematology & Oncology
- 賴香蘭 Division of Hematology & Oncology
- 林偉哲 Division of Radiology
- 劉建廷 Division of Hematology & Oncology
- 黃詩喻 Division of Hematology & Oncology
- 黃泰霖 Division of Hematology & Oncology
- 陳彥豪 Division of Hematology & Oncology
- 郭明濬 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 曹朝榮 Division of Hematology & Oncology
- 林正耀 Division of Hematology & Oncology
- 黃文聰 Division of Hematology & Oncology
- 陳昭勳 Division of Hematology & Oncology
- 陳彥勳 Division of Hematology & Oncology
- 蕭聖諺 Division of Hematology & Oncology
- Shang-Wen Chen Division of Hematology & Oncology
- 高婉真 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
45 participants
-
Global
862 participants
